Loading candles…
Mangalam Drugs & Organics Ltd, incorporated in 1977, operates in the pharmaceutical industry focusing on the manufacture of Active Pharmaceutical Ingredients (APIs) and intermediates. The company has established a notable presence in the global anti-malarial segment, backed by approvals from major international health organizations. Its business segments include the production of APIs and intermediates used in drug manufacturing. No specific information is provided on its founders, key management, headquarters, subsidiaries, or stock listings.
| MANGALAM : 20-Nov-2025 : The Company has informed the Exchange that a Board meeting to be held on November 13, 2025 has been re-scheduled. Further, the Comp… |
| 20 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 13 Nov 2025 |
| Intimation | Board Meeting Intimation to be held on 5th September, 2025 for approval of Appointment of Secretarial Auditor of the Company for the period of 5 Years and re… | 5 Sep 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | 7 Aug 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.